Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Sales (2016 - 2026)

Pharma-Bio Serv filings provide 16 years of Return on Sales readings, the most recent being 0.0% for Q1 2026.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Jan 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q1 2026 for Pharma-Bio Serv, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2023 to a low of 0.0% in Q3 2024.
  • Median Return on Sales over the past 5 years was 0.0% (2026), compared with a mean of 0.0%.
  • The widest YoY moves for Return on Sales: up 1bps in 2022, down 0bps in 2022.
  • Pharma-Bio Serv's Return on Sales stood at 0.0% in 2022, then plummeted by -135bps to 0.0% in 2023, then soared by 153bps to 0.0% in 2024, then plummeted by -101bps to 0.0% in 2025, then surged by 30276bps to 0.0% in 2026.
  • The last three reported values for Return on Sales were 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025) per Business Quant data.